Metoprolol represses PGC1α-mediated carnitine palmitoyltransferase-1B expression in the diabetic heart

Citations of this article
Mendeley users who have this article in their library.
Get full text


We have previously shown that metoprolol decreases carnitine palmitoyltransferase-1 (CPT-1) activity, a mechanism which may partly explain its beneficial effects in heart failure. It is possible that this effect occurs as a result of repression of cardiac CPT-1B expression. CPT-1B is induced by the transcription factors peroxisome proliferator activated receptor-α (PPAR-α) and PPAR-γ-coactivator 1α (PGC1α) and repressed by upstream stimulatory factor-2 (USF-2). We therefore hypothesized that metoprolol represses CPT-1B by increasing USF-2-mediated repression of PGC1α. Male Wistar Rats were divided into 4 groups: control, control treated with metoprolol for 5 weeks, diabetic and diabetic treated with metoprolol for 5 weeks. After termination, the expression of CPT-1 isoforms, PPAR-α, PGC1α USF-1 and USF-2, as well as downstream targets were measured. Binding of PPAR-α, PGC1α and USF-2 to PGC1α was measured using coimmunoprecipitation. The occupation of PPAR-α and MEF-2A consensus sites in the CPT-1B promoter was measured using chromatin immunoprecipitation assays. Chronic metoprolol treatment decreased the expression of CPT-1B in diabetic hearts. The expression of USF-2 was increased by metoprolol in both control and diabetic hearts, but the association of USF-2 with PGC1α was increased by metoprolol only in diabetic hearts. Metoprolol prevented the increase in PGC1α occupation of the CPT-1B promoter region observed in the diabetic heart without affecting PPAR-α occupation. Metoprolol decreases CPT-1B expression by decreasing PGC1α-mediated coactivation of PPAR-α and MEF-2A. This is associated with increased PGC1α/ USF-2 binding, suggesting that USF-2 mediates the metoprolol-induced repression of PGC1α. © 2009 Elsevier B.V. All rights reserved.




Sharma, V., Dhillon, P., Parsons, H., Allard, M. F., & McNeill, J. H. (2009). Metoprolol represses PGC1α-mediated carnitine palmitoyltransferase-1B expression in the diabetic heart. European Journal of Pharmacology, 607(1–3), 156–166.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free